JP2013533977A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533977A5
JP2013533977A5 JP2013518909A JP2013518909A JP2013533977A5 JP 2013533977 A5 JP2013533977 A5 JP 2013533977A5 JP 2013518909 A JP2013518909 A JP 2013518909A JP 2013518909 A JP2013518909 A JP 2013518909A JP 2013533977 A5 JP2013533977 A5 JP 2013533977A5
Authority
JP
Japan
Prior art keywords
biomarkers
level
m2pk
igfbp2
dkk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013518909A
Other languages
English (en)
Japanese (ja)
Other versions
JP6061344B2 (ja
JP2013533977A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/000895 external-priority patent/WO2012006681A1/en
Publication of JP2013533977A publication Critical patent/JP2013533977A/ja
Publication of JP2013533977A5 publication Critical patent/JP2013533977A5/ja
Application granted granted Critical
Publication of JP6061344B2 publication Critical patent/JP6061344B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013518909A 2010-07-14 2011-07-14 大腸癌の診断 Active JP6061344B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010903140A AU2010903140A0 (en) 2010-07-14 Diagnostic for colorectal cancer
AU2010903140 2010-07-14
PCT/AU2011/000895 WO2012006681A1 (en) 2010-07-14 2011-07-14 Diagnostic for colorectal cancer

Publications (3)

Publication Number Publication Date
JP2013533977A JP2013533977A (ja) 2013-08-29
JP2013533977A5 true JP2013533977A5 (enExample) 2014-09-18
JP6061344B2 JP6061344B2 (ja) 2017-01-18

Family

ID=45468816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518909A Active JP6061344B2 (ja) 2010-07-14 2011-07-14 大腸癌の診断

Country Status (13)

Country Link
US (2) US20130345322A1 (enExample)
EP (2) EP2593795A4 (enExample)
JP (1) JP6061344B2 (enExample)
CN (2) CN103140760B (enExample)
AU (1) AU2011279555B2 (enExample)
BR (1) BR112013000745B1 (enExample)
DK (1) DK2829881T3 (enExample)
ES (1) ES2653646T3 (enExample)
IN (1) IN2013CN01129A (enExample)
NO (1) NO2829881T3 (enExample)
PT (1) PT2829881T (enExample)
RU (1) RU2013103995A (enExample)
WO (1) WO2012006681A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011279555B2 (en) 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
MX2013008833A (es) 2011-02-02 2013-12-06 Amgen Inc Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r).
PT2883057T (pt) * 2012-08-09 2019-03-06 Univ Toulouse 3 Paul Sabatier Diagnóstico de insuficiência cardíaca
GB201218341D0 (en) * 2012-10-12 2012-11-28 Orign Sciences Ltd Diagnostic method
AU2015237229A1 (en) * 2014-03-28 2016-11-10 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
MX375557B (es) * 2014-07-18 2025-03-06 Sanofi Sa Método para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cáncer.
CN106191215B (zh) * 2015-04-29 2020-03-24 中国科学院上海生命科学研究院 肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
EP3294321B1 (en) * 2015-05-12 2024-07-31 Superlab Far East Limited Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
CN105219844B (zh) * 2015-06-08 2018-12-14 华夏京都医疗投资管理有限公司 一种筛查十一种疾病的基因标志物组合、试剂盒以及疾病风险预测模型
CN105021828B (zh) * 2015-07-20 2017-07-28 上海交通大学医学院附属新华医院 通过检测三期结直肠肿瘤患者血清预测肿瘤患者预后
CN105567846A (zh) * 2016-02-14 2016-05-11 上海交通大学医学院附属仁济医院 检测粪便中细菌dna的试剂盒及其在大肠癌诊断中的应用
JP6984862B2 (ja) * 2017-03-15 2021-12-22 国立大学法人金沢大学 血中ケモカインをマーカーとして用いた大腸癌の検出
CN107164535A (zh) * 2017-07-07 2017-09-15 沈阳宁沪科技有限公司 一种无创高通量甲基化结肠癌诊断、研究和治疗方法
CN110540588B (zh) * 2018-05-28 2022-08-23 香港中文大学 一种基于肿瘤干细胞标志物EpCAM的抗原表位多肽及其应用
CN108957014A (zh) * 2018-09-27 2018-12-07 郑州大学第附属医院 结直肠癌血清标志物、表达评估方法、试剂盒及应用
EP3870030A4 (en) * 2018-10-23 2022-08-03 Blackthorn Therapeutics, Inc. SYSTEMS AND METHODS FOR SCREENING, DIAGNOSIS AND STRATIFICATION OF PATIENTS
CN109504778B (zh) * 2019-01-11 2021-11-09 复旦大学附属中山医院 一种基于表观修饰的5hmC多分子标志物及结直肠癌早期诊断模型
JP2022522803A (ja) * 2019-03-01 2022-04-20 アドバンスド マーカー ディスカバリー エセ. エレ. 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー
JP7300660B2 (ja) * 2019-04-03 2023-06-30 京都府公立大学法人 大腸がんの検出方法
JP7032764B2 (ja) * 2019-04-03 2022-03-09 京都府公立大学法人 大腸がんの検出方法
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
US20220378877A1 (en) * 2019-11-13 2022-12-01 University Of Virginia Patent Foundation Treatment of clostridium difficile infections
EP3835789A1 (en) 2019-12-13 2021-06-16 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Biomarker panel for diagnosing colorectal cancer
WO2022130597A1 (ja) * 2020-12-18 2022-06-23 国立大学法人東北大学 推定装置、推定方法、推定プログラム、生成装置、及び、推定システム
CN117083525A (zh) * 2020-12-21 2023-11-17 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物
AU2022259871A1 (en) * 2021-04-20 2023-11-23 Vision Tech Bio Pty Ltd Biomarkers for colorectal cancer
CA3228665A1 (en) * 2021-08-11 2023-02-16 Trevor Lockett Method of detecting adenoma
WO2023128429A1 (ko) * 2021-12-31 2023-07-06 주식회사 이노제닉스 대장암 및 진행 선종의 선별 검사 방법 및 그 응용
WO2023128419A1 (ko) * 2021-12-31 2023-07-06 주식회사 이노제닉스 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용
CN114594259B (zh) * 2022-04-22 2022-09-13 北京易科拜德科技有限公司 一种新型的用于结直肠癌预后预测和诊断的模型及其应用
PL441319A1 (pl) * 2022-05-31 2023-12-04 Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu Zestaw biomarkerów białkowych i sposób diagnostyki raka jelita grubego in vitro
CN116219007A (zh) * 2022-09-15 2023-06-06 绍兴积准生物科技有限公司 检测结直肠癌的生物标志物组及其应用
CN119688988A (zh) * 2024-11-25 2025-03-25 中国医学科学院肿瘤医院 Timp1和foxp3作为诊断结直肠癌的生物标志物组合及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Timp1を用いた検出方法
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
EP2280285A1 (en) * 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
BRPI0401830A (pt) 2004-05-25 2006-01-17 Bentonit Uniao Nordeste Sa Processo de produção de pós granulados secos
US20080112888A1 (en) * 2006-06-30 2008-05-15 Schering Corporation Igfbp2 biomarker
US9060961B2 (en) 2006-11-09 2015-06-23 University Of Washington Molecules and methods for treatment and detection of cancer
US9353415B2 (en) * 2006-12-19 2016-05-31 Thomson Reuters (Scientific) Llc Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom
JP2010517582A (ja) 2007-02-12 2010-05-27 ザ・ジョンズ・ホプキンス・ユニバーシティー 結腸癌の早期検出および予後診断の方法
HUE028487T2 (en) * 2007-02-27 2016-12-28 Sentoclone Int Ab Detection of tumor cell multiplex using panel of agents associated with extracellular markers
WO2008116178A2 (en) * 2007-03-21 2008-09-25 Vanderbilt University Systems and methods for diagnosis and prognosis of colorectal cancer
CA2684024A1 (en) * 2007-05-10 2008-11-20 F. Hoffmann-La Roche Ag Use of timp-1 as a marker for colorectal cancer
WO2008144345A2 (en) * 2007-05-17 2008-11-27 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
WO2009037572A2 (en) * 2007-06-04 2009-03-26 Diagnoplex Biomarker combinations for colorectal cancer
US20090017463A1 (en) * 2007-07-10 2009-01-15 Vanderbilt University Methods for predicting prostate cancer recurrence
WO2009126543A1 (en) * 2008-04-08 2009-10-15 Nuclea Biomarkers, Llc Biomarker panel for prediction of recurrent colorectal cancer
US20100111969A1 (en) * 2008-10-31 2010-05-06 Apogenix Gmbh Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors
CN102300578A (zh) * 2008-12-01 2011-12-28 延寿有限责任公司 用于改变健康、安康和寿命的方法和组合物
WO2010065940A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
CN102326080B (zh) * 2009-02-20 2015-08-05 加利福尼亚大学董事会 A+生物标志物的试验
US20110177525A1 (en) * 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Antibodies and methods of diagnosing diseases
AU2011279555B2 (en) * 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer

Similar Documents

Publication Publication Date Title
JP2013533977A5 (enExample)
Yamamoto et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
Lee et al. Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC)
Bell et al. Assessment of cell‐cycle arrest biomarkers to predict early and delayed acute kidney injury
US20200033352A1 (en) Biomarker Panel For Diagnosing Cancer
US20220214345A1 (en) Colorectal cancer screening examination and early detection method
JP6419794B2 (ja) 主要な心臓有害事象に罹患する危険性を予測する方法
JP2016519285A5 (enExample)
Qiao et al. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
ES2908448T3 (es) Método para examinar el cáncer de hígado
ES2656082T3 (es) NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular
CN102947707B (zh) 前胃泌素和肝病理
JP2008529008A5 (enExample)
JP2012507030A5 (enExample)
Yajima et al. New assay system Elecsys anti-p53 to detect serum anti-p53 antibodies in Esophageal cancer patients and colorectal cancer patients: multi-institutional study
JP2017532577A5 (enExample)
Concepción et al. Novel Biomarkers for the diagnosis of diabetic nephropathy
JP2014224759A5 (enExample)
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
Akalya et al. Elevated urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein-7 predict drug-induced acute kidney injury
JP2018520366A5 (enExample)
JP7315965B2 (ja) ウィルス性肝癌の検出方法
JP2020514368A5 (enExample)
JP2015528562A5 (enExample)